Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-046365

Chairman and CEO bought 4,000 shares at an average $1.54 ($6,150)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2021-07-08 Purchase +2,000 $1.54 $3,080 10,785,571 D: show line 1 in the form
Niihara Yutaka Chairman and CEO 2021-07-09 Purchase +1,000 $1.54 $1,540 10,786,571 D: show line 2 in the form
Niihara Yutaka Chairman and CEO 2021-07-12 Purchase +1,000 $1.53 $1,530 10,787,571 D: show line 3 in the form
Open-market purchases · 4,000 sh · avg $1.54 · $6,150
Loading xslF345X03/doc4.xml…